Cargando…
Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
INTRODUCTION: The response to placebo is robust in studies of various antidepressant treatments. The strong placebo response, combined with the absence of side-effects, has prompted suggestions to use the ethically sound open-label placebo (OLP) as a treatment for depression. OBJECTIVES: The aim of...
Autor principal: | Nitzan, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479332/ http://dx.doi.org/10.1192/j.eurpsy.2023.1791 |
Ejemplares similares
-
Characteristics of unipolar depression in psychiatric inpatients
por: Kacem, M., et al.
Publicado: (2021) -
The Relation of Environment to Unipolar Recurrent Depression
por: Horesh Reinman, N.
Publicado: (2022) -
Therapeutic education program in adults with unipolar depression
por: Halouani, N., et al.
Publicado: (2023) -
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
por: Ekstrand, Joakim, et al.
Publicado: (2021) -
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients
por: Camardese, Giovanni, et al.
Publicado: (2015)